Drugs / S-606001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07123155 | Oct 2025 → Aug 2027 expected | glycogen storage disease due to acid maltase deficiency, late-onset | Shionogi | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | S-606001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07123155 ↗ |
| Route | Oral | “S-606001 administered orally” NCT07123155 ↗ |